85 related articles for article (PubMed ID: 11414750)
1. Mechanisms for induction of immunosuppression during experimental cryptococcosis: role of glucuronoxylomannan.
Chiapello L; Iribarren P; Cervi L; Rubinstein H; Masih DT
Clin Immunol; 2001 Jul; 100(1):96-106. PubMed ID: 11414750
[TBL] [Abstract][Full Text] [Related]
2. Immunosuppression, interleukin-10 synthesis and apoptosis are induced in rats inoculated with Cryptococcus neoformans glucuronoxylomannan.
Chiapello LS; Baronetti JL; Aoki MP; Gea S; Rubinstein H; Masih DT
Immunology; 2004 Nov; 113(3):392-400. PubMed ID: 15500627
[TBL] [Abstract][Full Text] [Related]
3. Enhanced gamma interferon production through activation of Valpha14(+) natural killer T cells by alpha-galactosylceramide in interleukin-18-deficient mice with systemic cryptococcosis.
Kawakami K; Kinjo Y; Yara S; Uezu K; Koguchi Y; Tohyama M; Azuma M; Takeda K; Akira S; Saito A
Infect Immun; 2001 Nov; 69(11):6643-50. PubMed ID: 11598033
[TBL] [Abstract][Full Text] [Related]
4. Heat killed cells of Cryptococcus neoformans var. grubii induces protective immunity in rats: immunological and histopathological parameters.
Baronetti JL; Chiapello LS; Aoki MP; Gea S; Masih DT
Med Mycol; 2006 Sep; 44(6):493-504. PubMed ID: 16966166
[TBL] [Abstract][Full Text] [Related]
5. Capsular polysaccharides galactoxylomannan and glucuronoxylomannan from Cryptococcus neoformans induce macrophage apoptosis mediated by Fas ligand.
Villena SN; Pinheiro RO; Pinheiro CS; Nunes MP; Takiya CM; DosReis GA; Previato JO; Mendonça-Previato L; Freire-de-Lima CG
Cell Microbiol; 2008 Jun; 10(6):1274-85. PubMed ID: 18284419
[TBL] [Abstract][Full Text] [Related]
6. Cryptococcus neoformans glucuronoxylomannan induces macrophage apoptosis mediated by nitric oxide in a caspase-independent pathway.
Chiapello LS; Baronetti JL; Garro AP; Spesso MF; Masih DT
Int Immunol; 2008 Dec; 20(12):1527-41. PubMed ID: 18927317
[TBL] [Abstract][Full Text] [Related]
7. In vitro human lymphocyte responses to Cryptococcus neoformans. Evidence for primary and secondary responses in normals and infected subjects.
Miller GP; Puck J
J Immunol; 1984 Jul; 133(1):166-72. PubMed ID: 6373927
[TBL] [Abstract][Full Text] [Related]
8. Anti-glucuronoxylomannan IgG1 specific antibodies production in Cryptococcus neoformans resistant mice.
Parra C; González JM; Castañeda E; Fiorentino S
Biomedica; 2005 Mar; 25(1):110-9. PubMed ID: 15962907
[TBL] [Abstract][Full Text] [Related]
9. Lack of involvement of nitric oxide in the macrophage-mediated inhibition of spleen cell proliferation during experimental cryptococcosis.
Rossi GR; Cervi LA; Sastre DA; Masih DT
Clin Immunol Immunopathol; 1998 Jan; 86(1):16-26. PubMed ID: 9434793
[TBL] [Abstract][Full Text] [Related]
10. Cryptococcal capsular glucuronoxylomannan reduces ischaemia-related neutrophil influx.
Ellerbroek PM; Schoemaker RG; van Veghel R; Hoepelman AI; Coenjaerts FE
Eur J Clin Invest; 2004 Sep; 34(9):631-40. PubMed ID: 15379763
[TBL] [Abstract][Full Text] [Related]
11. In vivo clearance of glucuronoxylomannan, the major capsular polysaccharide of Cryptococcus neoformans: a critical role for tissue macrophages.
Grinsell M; Weinhold LC; Cutler JE; Han Y; Kozel TR
J Infect Dis; 2001 Aug; 184(4):479-87. PubMed ID: 11471106
[TBL] [Abstract][Full Text] [Related]
12. Treatment of rats with heat killed cells (HKC) of Cryptococcus neoformans var. grubii induces cellular activation in spleen and lymphatic nodes.
Baronetti JL; Chiapello LS; Garro AP; Masih DT
Comp Immunol Microbiol Infect Dis; 2011 Jul; 34(4):327-34. PubMed ID: 21592577
[TBL] [Abstract][Full Text] [Related]
13. Apoptosis induction by glucuronoxylomannan of Cryptococcus neoformans.
Chiapello LS; Aoki MP; Rubinstein HR; Masih DT
Med Mycol; 2003 Aug; 41(4):347-53. PubMed ID: 12964728
[TBL] [Abstract][Full Text] [Related]
14. Cryptococcus neoformans capsular polysaccharide component galactoxylomannan induces apoptosis of human T-cells through activation of caspase-8.
Pericolini E; Cenci E; Monari C; De Jesus M; Bistoni F; Casadevall A; Vecchiarelli A
Cell Microbiol; 2006 Feb; 8(2):267-75. PubMed ID: 16441437
[TBL] [Abstract][Full Text] [Related]
15. An early imbalance of interleukin 12 influences the adjuvant effect of mannoproteins of Cryptococcus neoformans.
Pietrella D; Lupo P; Bistoni F; Vecchiarelli A
Cell Microbiol; 2004 Sep; 6(9):883-91. PubMed ID: 15272868
[TBL] [Abstract][Full Text] [Related]
16. Encapsulation of Cryptococcus neoformans with glucuronoxylomannan inhibits the antigen-presenting capacity of monocytes.
Retini C; Vecchiarelli A; Monari C; Bistoni F; Kozel TR
Infect Immun; 1998 Feb; 66(2):664-9. PubMed ID: 9453624
[TBL] [Abstract][Full Text] [Related]
17. Modification by suppressor cells and serum factors of the cell-mediated immune response in experimental pyelonephritis.
Miller T; Scott L; Stewart E; North D
J Clin Invest; 1978 Apr; 61(4):964-72. PubMed ID: 350900
[TBL] [Abstract][Full Text] [Related]
18. Induction of IL-10-producing CD4+CD25+ T cells in animal model of collagen-induced arthritis by oral administration of type II collagen.
Min SY; Hwang SY; Park KS; Lee JS; Lee KE; Kim KW; Jung YO; Koh HJ; Do JH; Kim H; Kim HY
Arthritis Res Ther; 2004; 6(3):R213-9. PubMed ID: 15142267
[TBL] [Abstract][Full Text] [Related]
19. T helper 1/T helper 2 cytokine imbalance in respiratory syncytial virus infection is associated with increased endogenous plasma cortisol.
Pinto RA; Arredondo SM; Bono MR; Gaggero AA; Díaz PV
Pediatrics; 2006 May; 117(5):e878-86. PubMed ID: 16618789
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of immune sera from human immunoglobulin transgenic mice immunized with a peptide mimotope of Cryptococcus neoformans glucuronoxylomannan.
Maitta RW; Datta K; Pirofski LA
Vaccine; 2004 Sep; 22(29-30):4062-8. PubMed ID: 15364457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
